Loading…

Brain Single Photon Emission Computed Tomography With Tc-99m MIBI or Tc-99m ECD in Comparison to MRI in Multiple Sclerosis

PURPOSE:To evaluate whether or not brain single photon emission computed tomography (SPECT) with Tc-99m MIBI or Tc-99m ECD (ethyl cysteinate dimer) can detect any abnormality in patients with definite multiple sclerosis (MS). We then compared these values with the results of T1, T2, and fluid-attenu...

Full description

Saved in:
Bibliographic Details
Published in:Clinical nuclear medicine 2010-09, Vol.35 (9), p.682-686
Main Authors: Assadi, Majid, Salimipour, Hooman, Seyedabadi, Mohammad, Saberifard, Jamshid, Javadi, Hamid, Nabipour, Iraj, Nemati, Reza
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3974-b86f29fa74fe382aa004535c9e992d1b0fb6e532856d30f60ceaea626554121b3
cites cdi_FETCH-LOGICAL-c3974-b86f29fa74fe382aa004535c9e992d1b0fb6e532856d30f60ceaea626554121b3
container_end_page 686
container_issue 9
container_start_page 682
container_title Clinical nuclear medicine
container_volume 35
creator Assadi, Majid
Salimipour, Hooman
Seyedabadi, Mohammad
Saberifard, Jamshid
Javadi, Hamid
Nabipour, Iraj
Nemati, Reza
description PURPOSE:To evaluate whether or not brain single photon emission computed tomography (SPECT) with Tc-99m MIBI or Tc-99m ECD (ethyl cysteinate dimer) can detect any abnormality in patients with definite multiple sclerosis (MS). We then compared these values with the results of T1, T2, and fluid-attenuated inversion recovery in magnetic resonance imaging (MRI). MATERIALS AND METHODS:A total of 16 patients with proved MS were enrolled in the study, and the MRI with and without gadolinium contrast and also brain SPECT with Tc-99m MIBI (8 cases) or Tc-99m ECD (8 other cases) were performed. RESULTS:MRI studies was performed in 16 patients (13 women and 3 men, aged 16–38 years) and an average of 10.47, 3.7, 5.3, 1.7, and 0.9 lesions was found in respect in periventricular white matter, juxtacortical white matter, corpus callosum, cerebellar peduncles, and brainstem, whereas brain SPECT with Tc-99m MIBI or Tc-99m ECD detected no abnormality. In addition, 6 cases had some degree of contrast enhancement. CONCLUSIONS:It seems that brain SPECT with Tc-99m MIBI or Tc-99m ECD would not improve this insufficiency. The small sizes of some plaques, particularly in chronic atrophic form of lesions, and the possibility of deeper anatomic positions of plaques can explain to some extent why the MS lesions were impossible to delineate on brain scan, although additional studies are needed.
doi_str_mv 10.1097/RLU.0b013e3181e9fa7a
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_748948311</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>748948311</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3974-b86f29fa74fe382aa004535c9e992d1b0fb6e532856d30f60ceaea626554121b3</originalsourceid><addsrcrecordid>eNpdUE1v1DAQtRCILoV_gJBvnFLGH3HiI10WWGlXoHYrjpaTnTQGZ53aiary6_FqW5CYy3xo3nszj5C3DC4Y6OrD1ebmAhpgAgWrGerOVvYZWbBSqAI418_JAoQSha4UPyOvUvoJwBRT8iU541CBAskW5PdltO5Ar93h1iP93ocpHOhqcCm5XCzDMM4T7ukuDOE22rF_oD_c1NNdW2g90O36ck1DfGpXy0_UnVA2upQJpkC3V-vjcDv7yY1Z47r1GENy6TV50Vmf8M1jPic3n1e75ddi8-3LevlxU7RCV7JoatXx43eyQ1FzawFkKcpWo9Z8zxroGoWl4HWp9gI6BS1atIqrspSMs0ack_cn3jGGuxnTZPJ7LXpvDxjmZCpZa1kLxvKmPG22-cAUsTNjdIOND4aBOZpusunmf9Mz7N2jwNwMuP8LenL5H-998BPG9MvP9xhNj9ZPvYEcAipecGAAOnfFcSTFH__CjNc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>748948311</pqid></control><display><type>article</type><title>Brain Single Photon Emission Computed Tomography With Tc-99m MIBI or Tc-99m ECD in Comparison to MRI in Multiple Sclerosis</title><source>HEAL-Link subscriptions: Lippincott Williams &amp; Wilkins</source><creator>Assadi, Majid ; Salimipour, Hooman ; Seyedabadi, Mohammad ; Saberifard, Jamshid ; Javadi, Hamid ; Nabipour, Iraj ; Nemati, Reza</creator><creatorcontrib>Assadi, Majid ; Salimipour, Hooman ; Seyedabadi, Mohammad ; Saberifard, Jamshid ; Javadi, Hamid ; Nabipour, Iraj ; Nemati, Reza</creatorcontrib><description>PURPOSE:To evaluate whether or not brain single photon emission computed tomography (SPECT) with Tc-99m MIBI or Tc-99m ECD (ethyl cysteinate dimer) can detect any abnormality in patients with definite multiple sclerosis (MS). We then compared these values with the results of T1, T2, and fluid-attenuated inversion recovery in magnetic resonance imaging (MRI). MATERIALS AND METHODS:A total of 16 patients with proved MS were enrolled in the study, and the MRI with and without gadolinium contrast and also brain SPECT with Tc-99m MIBI (8 cases) or Tc-99m ECD (8 other cases) were performed. RESULTS:MRI studies was performed in 16 patients (13 women and 3 men, aged 16–38 years) and an average of 10.47, 3.7, 5.3, 1.7, and 0.9 lesions was found in respect in periventricular white matter, juxtacortical white matter, corpus callosum, cerebellar peduncles, and brainstem, whereas brain SPECT with Tc-99m MIBI or Tc-99m ECD detected no abnormality. In addition, 6 cases had some degree of contrast enhancement. CONCLUSIONS:It seems that brain SPECT with Tc-99m MIBI or Tc-99m ECD would not improve this insufficiency. The small sizes of some plaques, particularly in chronic atrophic form of lesions, and the possibility of deeper anatomic positions of plaques can explain to some extent why the MS lesions were impossible to delineate on brain scan, although additional studies are needed.</description><identifier>ISSN: 0363-9762</identifier><identifier>EISSN: 1536-0229</identifier><identifier>DOI: 10.1097/RLU.0b013e3181e9fa7a</identifier><identifier>PMID: 20706041</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Brain - diagnostic imaging ; Brain - pathology ; Cysteine - analogs &amp; derivatives ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Multiple Sclerosis - diagnostic imaging ; Multiple Sclerosis - pathology ; Organotechnetium Compounds ; Technetium Tc 99m Sestamibi ; Tomography, Emission-Computed, Single-Photon ; Treatment Outcome</subject><ispartof>Clinical nuclear medicine, 2010-09, Vol.35 (9), p.682-686</ispartof><rights>2010 Lippincott Williams &amp; Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3974-b86f29fa74fe382aa004535c9e992d1b0fb6e532856d30f60ceaea626554121b3</citedby><cites>FETCH-LOGICAL-c3974-b86f29fa74fe382aa004535c9e992d1b0fb6e532856d30f60ceaea626554121b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20706041$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Assadi, Majid</creatorcontrib><creatorcontrib>Salimipour, Hooman</creatorcontrib><creatorcontrib>Seyedabadi, Mohammad</creatorcontrib><creatorcontrib>Saberifard, Jamshid</creatorcontrib><creatorcontrib>Javadi, Hamid</creatorcontrib><creatorcontrib>Nabipour, Iraj</creatorcontrib><creatorcontrib>Nemati, Reza</creatorcontrib><title>Brain Single Photon Emission Computed Tomography With Tc-99m MIBI or Tc-99m ECD in Comparison to MRI in Multiple Sclerosis</title><title>Clinical nuclear medicine</title><addtitle>Clin Nucl Med</addtitle><description>PURPOSE:To evaluate whether or not brain single photon emission computed tomography (SPECT) with Tc-99m MIBI or Tc-99m ECD (ethyl cysteinate dimer) can detect any abnormality in patients with definite multiple sclerosis (MS). We then compared these values with the results of T1, T2, and fluid-attenuated inversion recovery in magnetic resonance imaging (MRI). MATERIALS AND METHODS:A total of 16 patients with proved MS were enrolled in the study, and the MRI with and without gadolinium contrast and also brain SPECT with Tc-99m MIBI (8 cases) or Tc-99m ECD (8 other cases) were performed. RESULTS:MRI studies was performed in 16 patients (13 women and 3 men, aged 16–38 years) and an average of 10.47, 3.7, 5.3, 1.7, and 0.9 lesions was found in respect in periventricular white matter, juxtacortical white matter, corpus callosum, cerebellar peduncles, and brainstem, whereas brain SPECT with Tc-99m MIBI or Tc-99m ECD detected no abnormality. In addition, 6 cases had some degree of contrast enhancement. CONCLUSIONS:It seems that brain SPECT with Tc-99m MIBI or Tc-99m ECD would not improve this insufficiency. The small sizes of some plaques, particularly in chronic atrophic form of lesions, and the possibility of deeper anatomic positions of plaques can explain to some extent why the MS lesions were impossible to delineate on brain scan, although additional studies are needed.</description><subject>Brain - diagnostic imaging</subject><subject>Brain - pathology</subject><subject>Cysteine - analogs &amp; derivatives</subject><subject>Female</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Multiple Sclerosis - diagnostic imaging</subject><subject>Multiple Sclerosis - pathology</subject><subject>Organotechnetium Compounds</subject><subject>Technetium Tc 99m Sestamibi</subject><subject>Tomography, Emission-Computed, Single-Photon</subject><subject>Treatment Outcome</subject><issn>0363-9762</issn><issn>1536-0229</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNpdUE1v1DAQtRCILoV_gJBvnFLGH3HiI10WWGlXoHYrjpaTnTQGZ53aiary6_FqW5CYy3xo3nszj5C3DC4Y6OrD1ebmAhpgAgWrGerOVvYZWbBSqAI418_JAoQSha4UPyOvUvoJwBRT8iU541CBAskW5PdltO5Ar93h1iP93ocpHOhqcCm5XCzDMM4T7ukuDOE22rF_oD_c1NNdW2g90O36ck1DfGpXy0_UnVA2upQJpkC3V-vjcDv7yY1Z47r1GENy6TV50Vmf8M1jPic3n1e75ddi8-3LevlxU7RCV7JoatXx43eyQ1FzawFkKcpWo9Z8zxroGoWl4HWp9gI6BS1atIqrspSMs0ack_cn3jGGuxnTZPJ7LXpvDxjmZCpZa1kLxvKmPG22-cAUsTNjdIOND4aBOZpusunmf9Mz7N2jwNwMuP8LenL5H-998BPG9MvP9xhNj9ZPvYEcAipecGAAOnfFcSTFH__CjNc</recordid><startdate>201009</startdate><enddate>201009</enddate><creator>Assadi, Majid</creator><creator>Salimipour, Hooman</creator><creator>Seyedabadi, Mohammad</creator><creator>Saberifard, Jamshid</creator><creator>Javadi, Hamid</creator><creator>Nabipour, Iraj</creator><creator>Nemati, Reza</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201009</creationdate><title>Brain Single Photon Emission Computed Tomography With Tc-99m MIBI or Tc-99m ECD in Comparison to MRI in Multiple Sclerosis</title><author>Assadi, Majid ; Salimipour, Hooman ; Seyedabadi, Mohammad ; Saberifard, Jamshid ; Javadi, Hamid ; Nabipour, Iraj ; Nemati, Reza</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3974-b86f29fa74fe382aa004535c9e992d1b0fb6e532856d30f60ceaea626554121b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Brain - diagnostic imaging</topic><topic>Brain - pathology</topic><topic>Cysteine - analogs &amp; derivatives</topic><topic>Female</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Multiple Sclerosis - diagnostic imaging</topic><topic>Multiple Sclerosis - pathology</topic><topic>Organotechnetium Compounds</topic><topic>Technetium Tc 99m Sestamibi</topic><topic>Tomography, Emission-Computed, Single-Photon</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Assadi, Majid</creatorcontrib><creatorcontrib>Salimipour, Hooman</creatorcontrib><creatorcontrib>Seyedabadi, Mohammad</creatorcontrib><creatorcontrib>Saberifard, Jamshid</creatorcontrib><creatorcontrib>Javadi, Hamid</creatorcontrib><creatorcontrib>Nabipour, Iraj</creatorcontrib><creatorcontrib>Nemati, Reza</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Assadi, Majid</au><au>Salimipour, Hooman</au><au>Seyedabadi, Mohammad</au><au>Saberifard, Jamshid</au><au>Javadi, Hamid</au><au>Nabipour, Iraj</au><au>Nemati, Reza</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Brain Single Photon Emission Computed Tomography With Tc-99m MIBI or Tc-99m ECD in Comparison to MRI in Multiple Sclerosis</atitle><jtitle>Clinical nuclear medicine</jtitle><addtitle>Clin Nucl Med</addtitle><date>2010-09</date><risdate>2010</risdate><volume>35</volume><issue>9</issue><spage>682</spage><epage>686</epage><pages>682-686</pages><issn>0363-9762</issn><eissn>1536-0229</eissn><abstract>PURPOSE:To evaluate whether or not brain single photon emission computed tomography (SPECT) with Tc-99m MIBI or Tc-99m ECD (ethyl cysteinate dimer) can detect any abnormality in patients with definite multiple sclerosis (MS). We then compared these values with the results of T1, T2, and fluid-attenuated inversion recovery in magnetic resonance imaging (MRI). MATERIALS AND METHODS:A total of 16 patients with proved MS were enrolled in the study, and the MRI with and without gadolinium contrast and also brain SPECT with Tc-99m MIBI (8 cases) or Tc-99m ECD (8 other cases) were performed. RESULTS:MRI studies was performed in 16 patients (13 women and 3 men, aged 16–38 years) and an average of 10.47, 3.7, 5.3, 1.7, and 0.9 lesions was found in respect in periventricular white matter, juxtacortical white matter, corpus callosum, cerebellar peduncles, and brainstem, whereas brain SPECT with Tc-99m MIBI or Tc-99m ECD detected no abnormality. In addition, 6 cases had some degree of contrast enhancement. CONCLUSIONS:It seems that brain SPECT with Tc-99m MIBI or Tc-99m ECD would not improve this insufficiency. The small sizes of some plaques, particularly in chronic atrophic form of lesions, and the possibility of deeper anatomic positions of plaques can explain to some extent why the MS lesions were impossible to delineate on brain scan, although additional studies are needed.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>20706041</pmid><doi>10.1097/RLU.0b013e3181e9fa7a</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0363-9762
ispartof Clinical nuclear medicine, 2010-09, Vol.35 (9), p.682-686
issn 0363-9762
1536-0229
language eng
recordid cdi_proquest_miscellaneous_748948311
source HEAL-Link subscriptions: Lippincott Williams & Wilkins
subjects Brain - diagnostic imaging
Brain - pathology
Cysteine - analogs & derivatives
Female
Humans
Magnetic Resonance Imaging
Male
Multiple Sclerosis - diagnostic imaging
Multiple Sclerosis - pathology
Organotechnetium Compounds
Technetium Tc 99m Sestamibi
Tomography, Emission-Computed, Single-Photon
Treatment Outcome
title Brain Single Photon Emission Computed Tomography With Tc-99m MIBI or Tc-99m ECD in Comparison to MRI in Multiple Sclerosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T16%3A42%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Brain%20Single%20Photon%20Emission%20Computed%20Tomography%20With%20Tc-99m%20MIBI%20or%20Tc-99m%20ECD%20in%20Comparison%20to%20MRI%20in%20Multiple%20Sclerosis&rft.jtitle=Clinical%20nuclear%20medicine&rft.au=Assadi,%20Majid&rft.date=2010-09&rft.volume=35&rft.issue=9&rft.spage=682&rft.epage=686&rft.pages=682-686&rft.issn=0363-9762&rft.eissn=1536-0229&rft_id=info:doi/10.1097/RLU.0b013e3181e9fa7a&rft_dat=%3Cproquest_cross%3E748948311%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3974-b86f29fa74fe382aa004535c9e992d1b0fb6e532856d30f60ceaea626554121b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=748948311&rft_id=info:pmid/20706041&rfr_iscdi=true